1. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics;Anden, N.-E.; Butcher, S.G.; Corrodi, H.; Fuxe, K.; Ungerstedt, U.;European Journal of Pharmacology,1970
2. Effets cliniques et electroencephalographiques du metoclopramide en psychiatrie;Borenstein, P.; Bles, G.;Therapie,1965
3. Pyridoxine and Parkinsonism;Carter, S.M.;British Medical Journal,1973
4. Dystonic reactions in children caused by metoclopramide;Casteels-Van Daele, M.; Jaeken, J.; Schueren, P.van der; Zimmerman, A.; Bon, P.van den;Archives of Disease in Childhood,1970
5. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?;Costall, B.; Naylor, R.J.;Psychopharmacologia (Berl.),1973